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While somatic cell nuclear transfer (SCNT) techniques have been successfully implemented in several species to produce cloned embryos and
offspring, the efficiencies of the procedures are extremely low, possibly due to insufficient reprogramming of somatic nuclei. Employing
GeneChip microarrays, we describe global gene expression analysis of bovine in vitro fertilized (IVF) and SCNT blastocysts as well as respective
donor cell lines to characterize differences in their transcription profiles. Gene expression profiles of our donor cell lines were significantly
different from each other; however, the SCNT and IVF blastocysts displayed surprisingly similar gene expression profiles, suggesting that a major
reprogramming activity had been exerted on the somatic nuclei. Despite this remarkable phenomenon, a small set of genes appears to be aberrantly
expressed and may affect critical developmental processes responsible for the failures observed in SCNT embryos. Our data provide the most
comprehensive transcriptome database of bovine IVF and SCNT blastocysts to date.
© 2007 Elsevier Inc. All rights reserved.Keywords: Somatic cell nuclear transfer; Reprogramming; Bovine; Blastocyst; Donor cell; microarray; GeneChipIntroduction
The majority of nuclear transfer embryos/fetuses are lost
during different stages of pregnancy and often suffer from
serious developmental abnormalities of the sort that characterize
large offspring syndrome. Among the most frequently reported
problems in most cloned species are increased birth weight,
enlarged dysfunctional placenta, and vasculatory, metabolic and
endocrine organ failure (Farin et al., 2004; Hill et al., 2000a).
A successful nuclear transfer experiment requires the donor
nucleus to undergo a series of reprogramming events. In the
context of SCNT, the term “reprogramming” is used to define a
multifaceted process by which a somatic cell nucleus is
rendered into a physiological state capable of supporting
embryonic development. These processes include remodelling
somatic donor nuclei, silencing differentiation-associated⁎ Corresponding author. Fax: +1 517 432 8742.
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doi:10.1016/j.ydbio.2007.01.041genes, activating the genes critical for embryo development,
and reestablishing imprinting patterns (Latham, 2005). Al-
though these events are mainly driven by complex epigenetic
modifications of the somatic nucleus, they manifest themselves
as alterations in gene expression patterns. In this article, we use
the term “transcriptional reprogramming” to emphasize the
nature of the data we used to interpret the reprogramming events
taking place. Several studies indicate that most cloned embryos
display abnormalities in their DNA methylation patterns and
abnormal expression of several imprinted and nonimprinted
genes, suggesting a relationship between these aberrations and
the compromised developmental potential of SCNT-derived
embryos (Kang et al., 2002; Li, 2002; Nolen et al., 2005;
Rideout et al., 2001).
Gene expression studies in SCNT embryos have been
conducted mainly with cattle and mouse embryos, employing
qualitative, semiquantitative and quantitative approaches. Most
studies have focused on a small set of genes important for
embryogenesis, such as growth factors, growth factor binding
proteins, metabolic enzymes, transcription factors involved in
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products (Camargo et al., 2005; Daniels et al., 2000, 2001; Jang
et al., 2004, 2005; Li et al., 2005, 2006; Sawai et al., 2005;
Westhusin et al., 1999; Wrenzycki et al., 2001, 2004). These
studies have reported widespread abnormalities in gene ex-
pression in cloned animals, suggesting that transcriptional
regulation mechanisms might be impaired, possibly at different
levels of control, during the reprogramming process (Latham,
2005).
Large-scale analysis of gene expression in preimplantation
embryos and in cloned animals was reported first in mouse and
later in bovine models (Humpherys et al., 2002; Pfister-
Genskow et al., 2005; Smith et al., 2005; Somers et al., 2006).
The bovine studies were performed on SCNT-, in vivo- and in
vitro-produced bovine blastocysts using cDNA microarrays
with a limited number of probes. However, none of these studies
addressed the effect of donor cells.Fig. 1. Flow chart of the experimental design. CLLE: Low efficiency cell line; wh
efficiency cell line; when used in SCNT 45% of the embryos resulted in live offsprin
embryos produced using CLHE as donor nuclei. IVF: In vitro fertilized control embAvailable data suggest that the source of donor nuclei has
important implications for the outcome of cloning. Differences
in the abilities of donor cell lines to support embryonic
development have been reported (Kato et al., 2000; Pfister-
Genskow et al., 2005; Wakayama et al., 1999). In this study, we
have taken two different somatic cell lines whose capacity to
generate healthy SCNT-derived calves is significantly different
and hypothesized that, by comparing the overall gene expres-
sion profile of the cell lines prior to SCNT, the cloned embryos
derived from them, and the IVF embryos, we will be able to
elucidate some of the key genes responsible for, and/or
indicative of, successful reprogramming. Interestingly, the
majority of the genes in SCNT blastocysts had comparable
expression patterns to IVF blastocysts, with the exception of a
small number of genes whose relative expression levels were
similar to their corresponding donor cells, indicating a failure of
reprogramming in SCNT blastocysts.en used in SCNT 5% of the embryos resulted in live offspring. CLHE: High
g. NTLE: SCNT embryos produced using CLLE as donor nuclei. NTHE: SCNT
ryos.
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All chemicals were purchased from Sigma Chemical Company (St. Louis,
MO) unless otherwise stated. A flow chart of the experimental design is depicted
in Fig. 1.
Maturation and preparation of recipient oocytes
Recipient bovine oocytes were matured according to procedures previously
shown to produce developmentally competent oocytes (Fischer-Brown et al.,
2005). Bovine oocytes were obtained by aspiration of small antral follicles on
slaughterhouse-derived ovaries. Immature cumulus–oocyte complexes were
cultured in Tissue Culture Medium 199 (TCM-199) supplemented with 10%
fetal calf serum (FCS), 0.2 mM pyruvate, 25 μl/ml gentamicin, 0.5 μg/ml LH
(Sioux Biochemical, Sioux Center, IA) and 1 μg/ml estradiol-17β for 16–18 h at
39 °C with 5% CO2 in air. At 18 h after the start of maturation, cumulus cells
were removed from the oocytes by manual pipetting in the presence of 2 mg/ml
of hyaluronidase, and oocytes with extruded first polar bodies were selected for
enucleation. The oocytes were labeled with 0.5 μg/ml of DNA fluorochrome
(Hoechst 33342) for 20 min at 38.5 °C in C4 medium (Cyagra Inc.,
Elizabethtown, PA). All manipulations were performed in BO medium (Cyagra
Inc.) supplemented with 7.5 μg/ml of cytochalasin B on a Nikon TE2000-U
microscope equipped with Hoffman optics and Narishige micromanipulators.
The MII plate was removed by aspiration, using an enucleation pipette with a
25-μm inner diameter. To ensure that oocyte chromatin was removed, the
aspirated cytoplasm was exposed to UV light and examined for the presence of
the removed polar body and metaphase plate.
Adult fibroblast culture
Among the available donor cell lines we selected, two (LE: low efficiency
and HE: high efficiency) differed markedly in their culture characteristics and
developmental potential when used as nuclear transfer donors. Although both
donor cell lines were established from ear biopsies of adult cows, cell line LE
had a slow growth curve and larger diameter compared to cell line HE. When
employed as donor nuclei, both cell lines supported embryonic development to
blastocyst stage (10% and 11%, respectively) and established pregnancies at
comparable rates (68% and 70%). However, only one surviving offspring (5%)
was obtained from cell line LE, while cell line HE produced nine (45%)
(Supplementary Table 1). Donor cells were cultured in Dulbecco's modified
minimum essential medium (DMEM; Gibco BRL, Grand Island, NY)
supplemented with 20% FCS (Hyclone, Logan, UT) and antibiotic–antimycotic
(Gibco BRL) at 38.5 °C, under a gas phase of 5% CO2, 90% N2, 5% O2 and high
humidity until they reached approximately 70% confluency. Prior to nuclear
transfer, cells were disaggregated by trypsin–EDTA treatment.
Nuclear transfer, activation and fusion
A single donor cell was deposited into the perivitelline space of each
enucleated oocyte using a micropipette. NT couplets were activated using 5 μM
of ionomycin (Calbiochem, La Jolla, CA) in BO medium (Cyagra Inc.)
supplemented with 1 mg/ml of fatty-acid-free bovine serum albumin (BSA–
FAF) for 4 min, 24–26 h after the start of maturation. Immediately after
ionomycin treatment, nuclear transfer couplets were fused in sorbitol fusion
medium by applying a single electric pulse (15 μs each, 1.8–2 kV/cm). This was
followed by incubation of NT units in C4 medium (Cyagra Inc.) supplemented
with 5 μg/ml of cytochalasin B and 10 μg/ml of cycloheximide for 6 h. At the
end of incubation, NT units were washed in C4 medium and placed into culture
medium drops. Nonmanipulated, control metaphase-II-arrested oocytes were
parthenogenetically activated using the same protocol.
In vitro fertilization
For each nuclear transfer experiment, a group of mature oocytes was
fertilized with frozen–thawed sperm in 400 μl of glucose-free Tyrode's medium
supplemented with 6 mg/ml of fatty-acid-free BSA, 20 μM of penicillamine,
10 μM of hypotaurine, 1 μM of epinephrine and 2 μg/ml of heparin. Motilesperm were sorted by Percoll gradient centrifugation, and the final sperm
concentration in the fertilization drops was 1×106 sperm/ml. Fertilized oocytes
were incubated at 38.5 °C under a gas phase of 5% CO2 in air, and high humidity
for 20 h, stripped of cumulus cells by pipetting and transferred into embryo
culture medium C4.
Embryo culture
Activated SCNT and parthenogenic control embryos were cultured (10
embryos/50 μl drop) in C4 embryo culture medium (Cyagra Inc.) for the first
72 h, followed by incubation in C5 medium (Cyagra Inc.) until 7.5 days post-
activation. In vitro fertilized embryos were transferred in C4 medium following
removal of cumulus cells 20 h after fertilization and treated the same as
described for SCNT embryos.
A total of 120 blastocyts (40 NTLE, 40 NTHE, and 40 IVF) were produced
and used for microarray experiments.
Blastocyst collection and RNA isolation
Groups of ten excellent to good quality blastocysts were selected according
to International Embryo Transfer Society (IETS) guidelines, rinsed in sterile
PBS and lysed in 20 μl of extraction buffer (XB; Arcturus, Mountain View, CA)
in an Rnase-/Dnase-/Pyrogen-free 0.5-ml microcentrifuge tube on day 7.5 post-
activation/-fertilization. Each sample was incubated for 30 min at 42 °C,
centrifuged at 3000×g for 2 min and stored at −80 °C until use.
Total RNAwas isolated by using the PicoPure RNA Isolation Kit (Arcturus)
following the manufacturer's instructions except the elution volume was 6.5 μl.
All RNA samples within the purification column were treated with RNase-Free
DNase (Qiagen, Valencia, CA) and eluted with RNase-free elution buffer.
Isolated total RNA were evaluated for quality and quantity by employing
Agilent 2100 bioanalyzer with RNA 6000 Pico LabChip Kit (Agilent
Technologies, Santa Clara, CA), and approximately 600 pg of total RNA was
obtained from each blastocyst (Fig. 2A). Extracted RNA was stored at −80 °C
until use.
RNA amplification for GeneChip analysis (Supplementary Fig. 1)
First-strand cDNA synthesis was performed based on our previously
published protocol (Kocabas et al., 2006). Briefly, the following reagents were
added to each 0.5 ml of RNase-free tube: 5 μl total RNA (approximately 6 ng)
and 300 ng of an anchored T7-Oligo(dT)24 promoter primer (Ambion, Austin,
TX). The reaction tubes were incubated in a preheated PCRmachine at 70 °C for
2 min and transferred to ice. After denaturation, the following reagents were
added to each reaction tube: 1.4 μl of SMART II A oligonucleotide (5′
AAGCAGTGGTATCAACGCAGAGTACGCGrGrGr-3′) (Clontech, Mountain
View, CA), 4 μl of 5× first-strand buffer, 2 μl of 20 mM DTT, 0.6 μl of 5 μg/μl
T4 Gene 32 Protein (Roche, Indianapolis, IN), 2 μl of 10 mM dNTPs, 20 U of
RNase inhibitor (Ambion) and 1 μl of PowerScript Reverse Transcriptase
(Clontech). Total reaction volume was 20 μl. After gentle mixing, reaction tubes
were incubated at 42 °C for 60 min in a hot-lid thermal cycler. The reaction was
terminated by heating at 70 °C for 15 min and purified by a NucleoSpin
Extraction Kit (Clontech) following the manufacturer's instructions.
Double-stranded cDNA synthesis by long-distance (LD) PCR, cDNA
purification
PCR Advantage 2 mix (9 μl) was prepared as follows: 5 μl of 10X PCR
Advantage buffer (Clontech), 1 μl of 10 mM dNTPs, 100 ng of 5′SMART upper
primer (5′-AAGCAGTGGTATCAACGCAGAGTA-3′), 100 ng of 3′SMART
lower primer (5′-CGGTAATACGACTCACTATAGGGAGAA-3′), and 1 μl of
Polymerase Mix Advantage 2 (Clontech). This mix was added to 41 μl of the
first-strand cDNA synthesis reaction product, and thermal cycling was carried
out in the following conditions: 95 °C for 1 min followed by 19 cycles, each
consisting of denaturation at 94 °C for 30 s, annealing at 62 °C for 30 s, and
extension at 68 °C for 10 min. The cDNA was purified using a NucleoSpin
Extraction Kit (Clontech) following the manufacturer's instructions.
Fig. 2. (A) Digital RNA gel-like image showing the size distribution of the total RNA samples isolated from pools of five and ten blastocysts. L indicates RNA 6000
ladder. (B) Correlation coefficients among biological replicates of treatment groups. (C) Validation of significance analysis of microarray (SAM) data by real-time RT–
PCR. The genes were chosen arbitrarily and expression values were plotted on a log scale as fold change. Biological replicates are the same as used in microarray
experiments. CLLE: Low efficiency cell line; when used in SCNT 5% of the embryos resulted in live offspring. CLHE: High efficiency cell line; when used in SCNT
45% of the embryos resulted in live offspring. NTLE: SCNT embryos produced using CLLE as donor nuclei. NTHE: SCNT embryos produced using CLHE as donor
nuclei, IVF: In vitro fertilized control embryos.
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aRNA fragmentation
The purified double-stranded cDNA containing the T7 promoter sequence
was used as a template for IVT-labeling assays in the presence of biotin-labeled
ribonucleotides, using the BioArray HighYield RNA Transcript Labeling Kit
with T7 RNA polymerase (Enzo, Farmingdale, NY) as described by the
manufacturer. The biotin-labeled aRNA was purified using RNeasy mini
columns (RNeasy Mini Kit, Qiagen). In vitro transcription of the cDNA for each
replicate yielded 50–70 μg of biotinylated aRNA, and 15 μg of the labeled
aRNAwas fragmented at 94 °C for 35 min in 1× fragmentation buffer (40 mM
Tris–acetate, pH 8.1, 100 mM KOAc, 30 mM MgOAc).
Hybridization, washing, staining and imaging
The Affymetrix GeneChip System (Affymetrix, Santa Clara, CA) was used
for hybridization, staining and imaging of the arrays. Hybridization cocktails of
300 μl containing 15 μg of fragmented biotin-labeled aRNA and biotinylated
exogenous hybridization controls (50 pM control Oligo B2 and Eukaryotic
Hybridization Controls BioB at 1.5 pM, BioC at 5 pM, BioD at 25 pM and Cre
at 100 pM), herring sperm DNA (0.1 mg/ml), BSA (0.5 mg/ml) in buffer
(100 mM of MES, 1 M of NaCl, 20 mM of EDTA, 0.01% of Tween 20) were
hybridized to the GeneChip Bovine Array (Affymetrix). Hybridizations were
performed automatically, and each array was prehybridized with all components
except aRNA in a chamber at 45 °C for 15 min with rotation at 60 rpm. Each
microarray was hybridized with RNA cocktail for 16 h under the prehybridiza-tion conditions. After hybridization, the cocktail was removed from the chips,
and the array was filled with nonstringent wash buffer. The arrays were washed
according to Affymetrix protocol on a Fluidics station using nonstringent (6×
SSPE and 0.01% Tween 20) and stringent (100 mM of MES, 0.1 M of NaCl, and
0.01% Tween 20) wash buffers. To detect hybridized fragments, the microarray
was stained using SAPE (streptavidin linked to phycoerythrin) stain and
antibody solutions. SAPE contained 2 μg/μl of BSA, 10 μg/ml of streptavidin
phycoerythrin (SAPE) in 100 mM of MES, 1 M of NaCl, and 0.05% Tween 20.
The antibody solution also contained: 2 mg/ml of BSA, 0.1 mg/ml of goat IgG,
3 μg/ml of biotinylated anti-streptavidin antibodies in 100 mM of MES, 1 M of
NaCl, 0.05% Tween 20 and 0.005% antifoam. The order of staining was SAPE,
then antibody and second SAPE.
The arrays were scanned using an Affymetrix Genearray Scanner 3000 and
imaged using an Affymetrix GeneChip Operating System (GCOS) version 1.0
software (Affymetrix). The GCOS expression data report was generated for each
sample and used to judge the quality of sample preparation and hybridization.
The report included information about noise, background, and percentage of
probe sets called present based on the manufacturer's threshold and software
settings. Information about performance of exogenously added prokaryotic
hybridization control genes such as BioB, BioC and BioD of the E. coli biotin
synthesis pathway and the ratio of intensities of 3′ probes to 5′ probes for
housekeeping genes such asGAPDH and ACTBwere also included in the report.
Microarray experiments were performed in four and three replicates for
blastocysts and cells, respectively. One IVF blastocyst microarray was excluded
from the analysis due to poor quality of hybridization, but the rest of the samples
met the high-quality control standards defined by the manufacturer. Overall,
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software for donor cell and blastocyst samples, respectively.Real-time PCR validation of microarray results
A set of 11 genes were arbitrarily chosen to validate array results by using
real-time RT–PCR.
Samples of cDNA from blastocyst-stage SCNT and IVF embryos were
analyzed by real-time PCR using a GeneAmp 7000 system (PE Biosystems,
Foster City, CA). PCR products for 11 genes (AGOUTI, BMP4, COL6A1,
CRABP1, FGR, FMOD, MGP, MHC1, TXN, U2AF1L2, and CDH5) were
detected by SYBR Green chemistry. Primers were designed employing Primer
Express software and bovine target sequences for the probe sets on the
microarrays. PCR product sizes were between 71 and 85 bp (Supplementary
Table 2). PCR reactions were run in 96-well format as triplicates in a total
volume of 25 μl, which consisted of SYBR Green PCR Master Mix (Applied
Biosystems, Foster City, CA), 300 nM each of sequence specific primers and 1/
400 embryo equivalent of amplified cDNA. The amplification conditions were
as follows: preincubation at 50 °C for 2 min, DNA polymerase activation at
95 °C for 10 min, followed by 40 amplification cycles at 95 °C for 15 s and
60 °C for 45 s. At the end of the amplification cycles, a melting curve analysis
was performed to verify specific amplification. Melting curve data were
collected between 60° and 95 °C with a ramp time of 20 min. Amplified PCR
products were analyzed by using a standard curve method where five tenfold
serial dilutions of a pooled cDNAmixture were used to generate standard curves
for both the target and reference gene (bovine GAPDH). Before analysis had
taken place, optimization and validation procedures were followed for each
specific primer set.
Analysis of cDNAs derived from cell lines was carried out using the same
reaction conditions and using a 100-cell equivalent of cDNA. Data collection
and analysis were performed using a standard curve method as described
previously (Pfaffl et al., 2002). Standard curve dilutions were 5000-, 500-, 50-
and 5-cell equivalents of cDNA.
Statistical analysis
We used two different approaches for analysis of microarray data acquired
from donor cell lines—nuclear transfer and IVF blastocysts. First, we used the
absent and present (A/P) calls generated by Microarray Analysis Suite 5.0
(MAS 5) for each probe set to identify DE genes among cell lines and
blastocysts of different origin. In these analyses, our criterion for a probe set to
be included in the analysis was to be called “present” or “absent” on all arrays
of the corresponding sample. By this approach, a relatively small number of
genes were identified as DE among the samples of interest. The second
approach considered the differences in the level of gene expression and used
an analysis that allowed us to look at the data with more flexible criteria.
Significance analysis of microarrays (SAM) was employed to scrutinize data
using different cut-off values (false discovery rate and fold change) for
significance in the expression values. The cut-off values used to identify
differentially expressed genes in our study were 5% false discovery rate
(FDR), twofold changes for cell lines and 25% FDR, twofold changes for
blastocysts.
We used DE genes identified by SAM to identify biological pathways that
were overrepresented in the samples of interest. Since annotation of all bovine
probe sets on the arrays is not currently available, we used human ortholog
information for pathway analyses. We obtained the human orthologs of the
probe sets by searching publicly available sequence information (Refseq release
17) for the target sequences of the probe sets using Basic Local Alignment
Search Tool (BLAST) with a cut-off value of E=10−9. Of the 19,000 probe sets
on the Bovine GeneChip array, 15,000 corresponded to a human Unigene by our
BLAST criteria.
Statistical analysis of the data is based on A/P calls generated by MAS 5
software and Significance Analysis of Microarrays (SAM) to identify
differentially expressed transcripts among donor cells, nuclear transfer, and
in vitro produced embryos.
Data is normalized and analyzed using GeneChip Operating System (GCOS)
software, which employs a detection algorithm based on the target-specificintensity difference of the probe pair (perfect match/mismatch) relative to its
overall hybridization intensity to assign absent/present calls. Detection
p-values for each probe set were generated using one-sided Wilcoxon's signed
rank test and compared to predefined cut-off values to provide detection calls.
Log-transformed and quantile normalized data were used for SAM analysis.
A total of 14,896 probe sets were included in SAM, using the criterion that one
transcript needed to be present on at least three microarrays to be included in the
analysis. Multiclass and two-class unpaired tests were employed by the
software, generating 100 random permutations of group labels on the original
data to calculate FDR using t-statistics. The significant genes were selected
based on a comparison of observed and expected t-scores. A q-value, similar to
the p-value of conventional statistical tests, was assigned for each gene
detectable on the microarray to measure the lowest FDR at which a gene is called
significant (Mirkin et al., 2005; Tusher et al., 2001).
Real-time RT–PCR results were analyzed using expression values normal-
ized against bovine GAPDH, which was shown to be invariably expressed in the
original samples used for microarray experiments (p<0.01, data not shown).
One-way analysis of variance (ANOVA) and least significant difference (LSD)
were used for the statistical analyses.
Expression Analysis Systematic Explorer (EASE) was used to distinguish
biological processes that might be affected by the cloning experiments. EASE
is software developed to identify biological processes/themes in a given list of
genes using gene category overrepresentation analysis. Statistics created by
the software are standard Fisher's exact probability and a conservative variant
of it called “EASE score” that favours robust categories. The most significant
categories, as assessed by the EASE score, are defined as “themes” of the
gene list, an overrepresented class of genes in a sample/treatment condition,
as compared to a background population. Analyses of this kind allow a
functional interpretation of large microarray data sets (Hosack et al., 2003)
(http://david.niaid.nih.gov/david/ease.htm).
Some of the DE gene lists were analyzed by Ingenuity Software (Redwood
City, CA) to determine possible gene networks that could be interacting with DE
genes in our samples. Distribution of DE genes between IVF and SCNT
blastocysts on chromosomes were determined by a BLAST search against the
Bos taurus genome, and a chi square test was used to detect any clustering of
DE genes on chromosomes.
Results
Donor cell lines
Our microarray analysis revealed a very distinct gene
expression profile between two donor cell lines (LE: low
efficiency and HE: high efficiency). Of the 18,030 probe sets
analyzed, 308 and 403 transcripts were exclusively expressed in
donor cell lines LE and HE, respectively (Fig. 3A-a). When
Significance Analysis of Microarrays (SAM) was performed to
compare these cell lines using 5% FDR and at least twofold
changes (FC), out of 14,896 probe sets analyzed, the number of
differentially expressed (DE) transcripts was 3077 (Fig. 3B-a;
Supplementary Table 4). Expression Analysis Systematic
Explorer (EASE) analyses of these genes showed that
development, cell adhesion, cell communication, morphogen-
esis and organogenesis were the most overrepresented gene
ontology (GO) biological process categories (Fig. 3C-a and
Table 1a).
Donor cell lines vs. blastocysts
By absent/present (A/P) call analysis, 208 genes were found
to be exclusively expressed in somatic cells while 306 were
exclusively expressed in embryos (Fig. 3A-b). SAM results were
in agreement with this finding, identifying 5665 genes DE
Fig. 3. (A) Venn diagrams showing differentially expressed (DE) genes among cell lines and embryos based on A/P call analyses. (a) Donor cell line LE (CLLE) vs.
donor cell line HE (CLHE). (b) Donor cell lines, SCNT blastocysts (combined) and in vitro-produced blastocysts (IVF). (c) SCNT blastocysts produced from CLLE
(NTLE), SCNT blastocysts produced from CLHE (NTHE), and in vitro-produced blastocysts (IVF). (B) Significance analysis of microarrays (SAM) for the
comparison of gene expression in donor cell lines and blastocysts. Pie charts represent DE genes between a donor cell line LE (CLLE) and donor cell line HE (CLHE),
(b) donor cell lines (CL) and blastocysts (BLST), (c) NTLE and NTHE blastocysts, (d) SCNT blastocysts and their corresponding donor cell lines, (e) SCNT and IVF
blastocysts, (f) NTLE and IVF blastocysts, (g) NTHE and IVF blastocysts. Cut-off values for significance are 2-fold changes in expression and 5% FDR for cell lines
and 25% FDR for blastocysts. (C) Top ten functional categories overrepresented in genes differentially expressed between two donor cell lines. Gene ontology: (a)
biological process and (b) molecular function as detected by EASE.
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Table 5). When these genes were analyzed by EASE, the top five
overrepresented GO biological process pathways in the genes
upregulated in blastocysts were DNA metabolism, chromosome
organization and biogenesis, nuclear organization and biogen-esis, DNA replication and chromosome cycle and mitotic cell
cycle. The genes upregulated in the cell lines were concentrated
in pathways, such as morphogenesis, cell communication,
organogenesis, response to biotic stimulus, cell adhesion,
immune response, and defense response.
Table 1
Top ten functional categories overrepresented in genes differentially expressed
between two donor cell lines
Gene category Number of genes EASE score
(a) GO biological process
Development 243 2.30e−11
Cell adhesion 99 2.47e−11
Cell communication 370 8.03e−11
Morphogenesis 154 4.13e−10
Organogenesis 134 4.80e−09
Signal transduction 288 5.33e−06
Cellular process 724 9.75e−06
Response to pest/pathogen/parasite 56 0.00017
Cell–cell signalling 53 0.000252
Angiogenesis 14 0.00026
(b) GO molecular function
Signal transducer activity 250 1.61e−11
Cell adhesion molecule activity 72 2.46e−10
Receptor activity 149 2.69e−07
Receptor binding 65 4.80e−07
Transmembrane receptor activity 91 8.61e−07
Calcium ion binding 85 4.52e−06
Extracellular matrix structural constituent 23 2.35e−05
Growth factor activity 23 0.000356
Cytokine activity 23 0.000745
Chemoattractant activity 9 0.000885
Gene ontology, biological process, and molecular function are detected by
EASE.
Table 2







EST (RARB) CB467996 7.9 DNA-binding transcriptional
regulation
EST (WFDC1) BP107010 2.5 Tumor suppressor
EST (MGC4825) CK847648 0.6 Hypothetical protein
EST CK769502 0.2 Unknown
EST CK730195 0.3 Unknown
EST (U2AF1) CK777968 10.0 RNA binding, splicing
EST (2202255A) BF045148 2.2 AT motif-binding factor 1
EST BE749769 7.6 Unknown
EST (KIF22) BM480588 1.4 Cytokinesis, chromosome
separation
EST CB461355 1.6 Unknown
TUFT1 NM74479.2 1.6 Mineralization and structural
organization of enamel
EST (wds) CK979546 1.4 Morphogenesis, oogenesis
EST CB463992 1.7 Unknown
MHC1 M21044.1 2.3 Antigen presentation
CRABP1 M36808.1 7.5 Steroid binding
EST BF041173 1.6 Unknown
EST (FLJ10539) CK816927 1.5 Hypothetical protein
THBS2 NM176872.1 2.7 Synaptogenesis
EST (MGC14141-
moderate)
CK949814 1.7 Hypothetical protein
EST CB419193 2.2 Unknown
FC: fold change in IVF blastocysts compared to SCNT blastocysts.
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According to A/P call analysis, only three genes were DE
among blastocysts, two upregulated (CEP1, SERPNB5) in
SCNT blastocysts and one (U2AF1L2) in IVF blastocysts,
indicating that a considerable amount of reprogramming
activity has been exerted on donor nuclei (Fig. 3A-b). These
results were consistent with SAM, which identified only 20
genes as DE (Fig. 3B-e). Of these 20 genes, three were defined
bovine genes, 10 were bovine sequences with a moderate to
strong similarity to human genes, and seven were unknown
bovine ESTs (Table 2).
When SCNT blastocysts of different origin were compared
by A/P calls, 12 probe sets – nine in SCNT from the LE (NTLE)
cell line and three in SCNT from the HE (NTHE) cell line –were
differentially expressed (Fig. 3A-c). SAM identified 212 probe
sets differentially expressed between NTLE and NTHE (120 in
NTLE, 92 in NTHE upregulated; Fig. 3B-c and Supplementary
Table 9), at 25% FDR and only seven (6 in NTHE and 1 in NTLE
upregulated) at 5% FDR. Comparison of NTLE and NTHE
blastocysts to IVF blastocysts by SAM identified only 9 and 19
DE genes, respectively (Fig. 3B-f and -g). When we used a more
conservative FDR of 5%, only two genes were DE between
NTLE and IVF blastocysts.
Hierarchical clustering of all probe sets used in SAM
analyses has classified two donor cells and blastocysts.
Clustering of the blastocysts were not according to their origin
indicating small differences in gene expression profiles of
embryos as opposed to donor cell lines where two distinct
clusters identified correctly (Fig. 4).Validation of microarray results
Eleven arbitrarily chosen genes were used to validate array
results (six on blastocysts and five on cell lines). All genes
except for MHC1 were up- or downregulated in consistent with
the SAM results (Fig. 2C). Quantitative differences in five
transcripts observed in cell lines were significant according to
both analyses. Significance levels of differences in five of six
genes tested on blastocysts were similar in both assays
(Supplementary Table 3).
Discussion
Gene expression profile of donor cell lines
Using our strict A/P call criterion, out of 18,030 probe sets
analyzed, we identified 308 and 403 transcripts that were
expressed exclusively in donor cell lines LE and HE,
respectively. The number of DE probe sets identified by SAM
was 3077. It is not surprising to see different expression profiles
between donor cells; however, the magnitude of these
differences is somewhat interesting to note. This finding may
be rooted in their clear phenotypical characteristics and under-
lines the fact that donor cell lines, while extracted from the same
region of the skin of the animals, could exert a significant effect
on the outcome of cloning (Amano et al., 2001; Hill et al., 2000b;
Li et al., 2006; Tsunoda and Kato, 2002). Since no study has
investigated the expression profiles of donor cells, we could not
compare our results with any other donor cell lines.
Fig. 4. (A) Representative heat map of 14,896 probe sets used for hierarchical clustering of all samples in the study. Note that hierarchical clustering of probe sets
classified biological replicates of donor cell lines as distinct groups while the biological replicates of SCNT and IVF blastocysts were not classified based on their
origin. Heat map was constructed using normalized expression values. Red and blue colors indicate high and low expression levels, respectively. (B) Table showing
different comparisons done by SAM, number and percentage of DE genes. CLLE: Low efficiency cell line; when used in SCNT 5% of the embryos resulted in live
offspring. CLHE: High efficiency cell line; when used in SCNT 45% of the embryos resulted in live offspring. CL: donor cell lines, BLST: blastocysts. NTLE: SCNT
embryos produced using CLLE as donor nuclei. NTHE: SCNT embryos produced using CLHE as donor nuclei, IVF: In vitro fertilized control embryos.
644 Z. Beyhan et al. / Developmental Biology 305 (2007) 637–649We paid particular attention to gene categories thought to be
affected by SCNT, such as chromatin remodelling and gene
imprinting, since differential expression of these genes might
have implications for how somatic nuclei respond to reprogram-
ming activity of the oocyte. We analyzed 52 chromatin-
remodelling-related genes in our microarray; nine were DE
between cell lines: ASF1B, CBX6, FLJ21103, HDAC1,
HDAC6, HDAC8, HDAC9, RING1, and RNF2. Our analysis
contained 29 orthologs of known imprinted human genes, nine
of which were DE: CDKN1C, COPG2, DCN, GATM, MEST,
NDN, NNAT, PON3, and SGCE. Even though EASE analysis
did not identify them as overrepresented themes, small
differences in the expression of certain genes can trigger a
ripple effect on cellular processes, leading to the demise of the
cloned embryo (Dodge et al., 2004; Natale et al., 2001).
Gene expression profile of blastocysts
The number of differentially expressed genes between SCNT
and IVF embryos was remarkably low. Only three genes, CEP1
and SERPNB5 in SCNT blastocysts and U2AF1L2 in IVF
blastocysts, were differentially expressed. Along with the known
genes identified as DE by SAManalysis, these genes are involvedin biological processes such as transcriptional regulation (RARB,
CRABP), RNA processing (U2AF1), signal transduction
(SERPNB5), antigen presentation (HLA-A), centrosome organiza-
tion and cytokinesis (CEP1, KIFF22), cell adhesion and
migration (THBS2) and tissue mineralization (TUFT1).
While array analyses are not best suited tools to determine
the function of individual genes, it is tempting to speculate
about a number of possible mechanisms involved in differential
regulation of IVF and SCNT embryo development. These
questions need to be addressed using more robust quantification
methodologies.
U2AF1L2 is a conserved protein involved in RNA splicing.
The gene is mapped to the X chromosome in mice, humans and
cattle. Expression of U2AF1L2 is not restricted to certain
tissues; however, its level of expression changes with the
activity of the cell (Pacheco et al., 2004). It is curious to observe
the expression of this gene only in IVF blastocysts but not in the
cell lines or SCNT blastocysts. This could indicate failed
reactivation of the gene and could possibly lead to serious
consequences due to its intrinsic ability to affect many cellular
processes.
Using the Ingenuity Pathway Analysis (IPA) database, in
Fig. 5 we present a network of genes that could interact with
Fig. 5. Functional network of genes differentially expressed between IVF and SCNT blastocysts, based on the Ingenuity Pathway Analysis (IPA) database. Genes
marked red and green are upregulated and downregulated in IVF blastocysts. Straight and dashed lines between gene products indicate direct and indirect interactions.
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network are worth noticing. Retinoic acid receptor B (RARB)
and cellular retinoic acid-binding protein 1 (CRABP1) were
significantly downregulated in SCNT blastocysts (sevenfold).
Since differentially expressed HLA-A, THBS2, and SERPINB5
are linked directly or indirectly to the RA pathway, it is
tempting to speculate about a possible role for this signalling
pathway in the failures observed in cloned bovine embryos
during embryogenesis. It has been previously shown that
mouse, bovine and human blastocysts express retinoic acid
(RA) receptors and respond to retinols (Hidalgo et al., 2005;
Huang et al., 2005, 2003; Lima et al., 2005). While the exact
role of RA has not yet been clearly defined, it is evident that
the RA-signalling pathway is active during preimplantation
development. The upregulation of RA-signalling molecules in
IVF, as compared to SCNT embryos, deserves further
investigation.
Another interesting observation we have made in regard to
DE genes between IVF and SCNT blastocysts was the absence
of CEP1 expression in IVF embryos while exclusivelyexpressed in all SCNT embryos. CEP1 is one of the several
pericentriolar matrix proteins localized at the site of centroso-
mal duplication just before mitosis. Microinjection of anti-
CEP1 antibodies into HeLa cells disrupted the structure of
centrosomes and resulted in ectopic localization of centrosomal
proteins in the cytoplasm (Hinchcliffe, 2003; Ou et al., 2002).
Although the role of CEP1 during embryonic development has
not been studied, global gene expression profiling indicated
that CEP1 transcripts are not detected or are detected at very
low levels in mouse (Su et al., 2002; Zeng and Schultz, 2005)
and bovine (Geo Dataset: GDS730) preimplantation embryos.
These observations agree with our microarray results and could
have interesting implications in light of recent publications
suggesting the functional nonequivalence of somatic and
embryonic centrosomes in the context of SCNT.
An increased frequency of ploidy problems in cloned
embryos has been reported elsewhere (Booth et al., 2003;
Nolen et al., 2005; Shi et al., 2004), indicating a failure or
inefficiency in chromosome segregation during mitotic cycles.
Miyara et al. (2006) reported that removal of mitotic spindles
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proteins, such as calmodulin, PLK1, TCTP, HSET, Eg5, Ran,
Aurora A, GSKα, and GSKβ. Nevertheless, their quantity was
restored 3 h after enucleation. Calmodulin, however, was
incapable of associating with the mitotic spindle in SCNT
constructs, as opposed to embryonic blastomere and ES cell
nuclear transfer constructs, and remained altered during the first
and second mitotic divisions. In addition, removal of somatic
centrosomes before nuclear transfer led to bipolar spindles and
correct alignment of chromosomes (Van Thuan et al., 2006).
Taken together, these observations suggest a functional
difference between somatic and embryonic centrosomes and
spindle assembly. The absence of CEP1 and the elevated levels
of KIFF22 – a kinesin molecule – in IVF blastocysts compared
to SCNT, give credence to the notion that these proteins play a
significant role in determining the success or failure of SCNT
embryos, and they deserve further investigation.
The differences in gene expression profiles of IVF and
SCNT blastocysts did not imply a direct connection between
these profiles and developmental potential of the donor cells.
Considering that the gene expression profiles of SCNT
blastocysts produced from low and high efficiency cell lines
were not noticeable different from IVF blastocysts (Fig. 3B-f
and -g), global gene expression profiles of SCNTembryos at the
blastocyst stage, may not be a good indicator of developmental
potential of clone embryos. These observations are in agreement
with the well established fact that development of SCNT
embryos to blastocyst stage does not correlate with their ability
to develop into live offspring. Two previous global gene expres-
sion analyses also reported relatively small differences between
the transcriptome profiles of IVF and SCNT blastocysts.
Expression profiles of cell lines vs. SCNT blastocysts
SAM identified 5665 probe sets as differentially expressed
between donor cell lines and embryos. Distribution of these
genes into functional categories by EASE identified pathways
that are expected to be active in embryos, such as DNA
metabolism, chromosome organization, nuclear organization
and biogenesis, DNA replication, mitotic cell cycle, and RNA
metabolism. Several networks of functional pathways identified
in the IPA database were also indicative of the embryonic origin
of DE genes. Supplementary Fig. 2 depicts one of the repre-
sentative networks.
Although the majority of the DE genes between the two
donor cell lines were not significantly different in SCNT and
IVF blastocysts, we have identified a small set of genes that
maintained their relative expression levels in both cell lines and
in their corresponding SCNT blastocysts. Out of 70 probe sets
that were differentially expressed in both cell lines and SCNT
blastocysts, 47 nonredundant transcripts kept their relative level
of expression (Table 3) at the blastocyst stage. The frequency of
genes that maintained their relative expression level is
significantly higher than a random probability assumption
(p<0.01), suggesting that these genes could be of interest as
candidates for genes that failed to be reprogrammed. These
genes are involved in biological functions such as cellmorphology, post-translational modification, gene expression,
cell cycle, cellular function, carbohydrate metabolism, cell
signalling, and vitamin and mineral metabolism. Considering
their possible interactions with other molecules, it is likely that
these genes take part in a wide array of processes responsible for
embryo development and reprogramming.
Neuronatin (NNAT) is an imprinted and paternally expressed
gene in humans. NNAT in mice maps to the distal portion of
mouse chromosome 2, which contains an imprinting region
associated with morphologic abnormalities and early neonatal
lethality. It is initially expressed in the fetal brain and pituitary
gland and later, more widely, in the central and peripheral
nervous system, mainly in postmitotic and differentiating
neuroepithelial cells (Kikyo et al., 1997). NNAT transcripts
were not detected during preimplantation development in mice,
including at the blastocyst stage (Kikyo et al., 1997) while
bovine embryos express it at the blastocyst stage (Ruddock et
al., 2004). In our data set its expression is elevated in CLLE and
NTLE blastocysts compared to CLHE and IVF blastocysts.
Upregulation of NNAT in our inefficient cell line and embryos,
coupled with its imprinted nature, highlights its significance in
the context of SCNT. Several line of evidence indicate that
developmental problems associated with the SCNT embryos
might be caused by failure of epigenetic remodelling of donor
nuclei (Armstrong et al., 2006; Mann et al., 2003; Rideout et al.,
2001).
Consistent differential expression of an imprinted gene in the
donor cell and the resulting embryo clearly indicates incomplete
epigenetic remodelling. This observation also implies that while
most of the genome can be successfully reprogrammed, there
are certain genes of the donor nuclei that are more resistant to
the remodelling capacity of the oocyte's cytosol and therefore
be solely responsible for the developmental success or failure of
the reconstructed embryo.
When we compare our gene expression data with three other
available microarray studies on bovine cloned blastocysts
(Pfister-Genskow et al., 2005; Smith et al., 2005; Somers et
al., 2006), the most striking observation is that DE genes
between SCNT and IVF embryos in all three data sets were
completely different. The dissimilarity among these data sets
might be a consequence of several factors, such as: 1) differences
in the microarray platforms employed, 2) sources of donor cells,
and 3) other experimental variables, such as activation, culture
conditions and cryopreservation. Donor cells in the study by
Pfister-Genskow et al. (2005) were derived from the genital
ridge of fetuses, while Smith et al. (2005) and Somers et al.
(2006) employed adult fibroblasts, as we did in our study. In the
study by Smith et al., the number of DE genes between donor
cells and SCNT blastocysts was 1546, representing 29% of the
genes analysed. The same comparison in our study resulted in
5540 out of 14,896 DE probe sets, representing 37% of the genes
analyzed. Pfister-Genskow et al. (2005) and Somers et al.
(2006), however, did not determine the expression profiles of
their donor cells. Several studies addressing the effects of
experimental protocols on expression of certain genes in SCNT-
derived bovine embryos have suggested a subtle interaction of
experimental protocols and expression patterns (Wells et al.,
Table 3
Genes differentially expressed in both donor cells and respective SCNT blastocysts
Gene Accession number FC embryos FC cells Function
(a) Genes upregulated in both cell line HE and NTHE compared to cell line LE and NTLE, respectively
ANG CB439555 5.83 18.16 Angiogenesis, morphogenesis
ASIP X99692.1 5.08 6.78 Lipid metabolism, signal transduction, pigmentation
BCL11B BM446374 6.28 10.93 Tumor suppressor, thymocyte development
C1R CK950026 1.90 10.95 Humoral defense, complement activation
ENOSF1 BE722206 2.37 24.06 Mitochondrial metabolism
EPAS1 CK963545 2.43 118.85 Transcriptional regulation, organogenesis, signal transduction
EST CB435699 3.49 2.31 Unknown
EST BE753986 4.55 10.32 Unknown
EST CK967060 2.71 3.12 Unknown
FKBP9 CK727180 1.86 2.02 Protein metabolism
MIPOL1 CK771895 6.92 2.59 Microtubule biogenesis and organization
MYO1C Z22852.1 1.99 3.41 Cytoskeleton and organelle organization
PPP1R3C BP104788 13.54 6.22 Phosphatase, biosynthetic activity
QPCT NM177506.2 3.16 10.25 Transferase activity
RP42 BM254059 1.58 2.70 Neurogenesis
S100A1 CK770139 4.70 3.88 Organogenesis, signal transduction
S100A13 NM205800.1 5.79 6.46 Cell differentiation, signal transduction
S100A2 BF043546 2.34 2.61 Calcium and metal ion binding
SELENBP1 CB439619 3.64 3.32 Cell growth, transport, signal transduction
SFN CK847195 2.00 2.05 Tumor suppressor, cell cycle regulation
STEAP2 CB442056 2.84 24.87 Electron transport
UNQ501 CK958905 2.78 4.93 Unknown
(b) Genes downregulated in both cell line HE and NTHE compared to cell line LE and NTLE, respectively
ABCC4 BF774459 0.34 0.07 ATP-dependent transporter activity
ACSL4 CK848123 0.45 0.41 Lipid biosynthesis
ALS2CR3 CB439500 0.20 0.16 Cell growth, neurotransmitter, signalling
ARRB1 BI540546 0.53 0.13 Signal transduction,
C17orf40 CB461659 0.50 0.34 Unknown
DMD CK973044 0.19 0.04 Cell motility, muscle development
DTWD2 CK846413 0.32 0.47 Unknown
EST AU276076 0.33 0.02 Unknown
EST CB431633 0.40 0.28 Unknown
EST CB452282 0.20 0.05 Unknown
EST CB421665 0.35 0.01 Unknown
EST CK776524 0.24 0.15 Unknown
EST CK776345 0.20 0.22 Unknown
EST CK845971 0.14 0.19 Unknown
EST (HEM6) CK776863 0.48 0.33 Unknown
GRIP2 CK957740 0.18 0.05 Neural signalling
HLA-A CK849540 0.14 0.02 Antigen processing, presentation
HLA-DRB1 CK940528 0.30 0.35 Antigen processing, MHC II receptor activity
LAMA4 AW659827 0.24 0.09 Cell communication, cell adhesion, extracellular matrix
NNAT CK771127 0.36 0.08 Neurogenesis, transporter activity
RAD52B CK847251 0.49 0.12 Nucleic acid binding
SEC15L1 CB460230 0.57 0.14 Vesicular transport, iron metabolism
SYNPO CB460406 0.63 0.25 Cell motility, neurogenesis
UPP1 CK778858 0.39 0.05 Unknown
VARS CK975180 0.52 0.47 Protein synthesis
647Z. Beyhan et al. / Developmental Biology 305 (2007) 637–6491999; Wrenzycki et al., 2001). Another complicating factor in
comparing our results with those reported by Smith et al. is the
fact that blastocysts used in that study were cryopreserved by
vitrification and were thawed prior to RNA isolation, as opposed
to our embryos, which were used right at the end of culture
period. One recent study has suggested that the expression
profile of certain genes, such as Hsp70, MnSOD, CuSOD,
CirpB, Rbm3, and Trp53, could be altered by vitrification in
mouse embryos (Boonkusol et al., 2006). Despite the fact that
there are differences in the methods as well as in expression
profiles at the single-gene level in all three data sets, one aspectshared by all the studies was the low number (less than 1%) of
DE genes between SCNT and IVF embryos at the blastocyst
stage, suggesting that most of the genes are reprogrammed and
that the 1% that fail to do so may be responsible for the
embryonic losses. An alternative explanation for the similarity in
expression profiles of blastocysts, regardless of their origin,
could be the possibility of random misregulation of genes in the
clone embryos. This could increase the variation and mask the
differences in the level of expression at individual gene level.
Accumulation of these aberrations, in turn might result in
deleterious consequences later in development.
648 Z. Beyhan et al. / Developmental Biology 305 (2007) 637–649We have been able to identify a subset of genes that are
differentially expressed between the two cell lines prior to and
after SCNT. Relative expression levels that are persistent in
donor cells and corresponding SCNT blastocysts could also
imply some residual components in donor cell which is
resistant to remodelling activities of recipient cytoplasm.
Conclusions
Overall, our microarray experiments provide the most
comprehensive database of gene expression profiles of bovine
IVF and SCNT blastocysts, along with the profiles of two adult
fibroblast cell lines. While we have found striking differences in
the gene expression profiles of the two donor cells prior to
SCNT, such profiles were almost completely reprogrammed by
the time the SCNT embryo reached the blastocyst stage. Our
data argues in favor of the now widely held view that the oocyte
cytoplasm is capable of silencing and reactivating a large array
of genes in a remarkably short time period. Still, there are
significant differences between the two cell lines in their
capacity to generate healthy offspring. One can argue that one
cell line is more susceptible to reprogramming than the other
and that although the overall gene expression profile at the
blastocyst stage seems to be quite similar, post-transcriptional
modifications could be responsible for the different perfor-
mances of these two cell lines and their SCNT embryos after
transfer into the uterus. It is therefore worth considering that
although the oocyte seems capable of dealing with any kind of
nuclei, the importance of the donor cell source in cloning
experiments should not be underestimated. We have found a
small set of genes, identified in our study as DE genes, that
could be responsible for the developmental failures of cloned
embryos and for triggering a series of cumulative aberrations
incompatible with fetal development.
Taken together, our findings will help researchers in the field
design-specific hypothesis-driven experiments with the aim of
elucidating the molecular mechanism of nuclear reprogramming
during SCNT.
Acknowledgments
We are especially thankful to Drs. Annette Thelen and Jeff
Landgraf at the Research Technology Support Facility (RTSF)
for expertise in Affymetrix GeneChip hybridizations; to Dr.
Peter Saama for his assistance for bioinformatics and software-
related questions, and to the members of the Cellular
Reprogramming Laboratory for their support during the course
of the study. We would like to acknowledge Cyagra, Inc.,
personnel for providing pregnancy data and donor cell lines
used in this study. Funding was provided by MSU Foundation,
The Office of the Vice President of Research and Graduate
Studies and the Michigan Agricultural Experiment Station.
Appendix A. Supplementary data
Supplementary data associated with this article can be found,
in the online version, at doi:10.1016/j.ydbio.2007.01.041.References
Amano, T., Kato, Y., Tsunoda, Y., 2001. Full-term development of enucleated
mouse oocytes fused with embryonic stem cells from different cell lines.
Reproduction 121, 729–733.
Armstrong, L., Lako, M., Dean, W., Stojkovic, M., 2006. Epigenetic
modification is central to genome reprogramming in somatic cell nuclear
transfer. Stem Cells 24, 805–814.
Boonkusol, D., Gal, A.B., Bodo, S., Gorhony, B., Kitiyanant, Y., Dinnyes, A.,
2006. Gene expression profiles and in vitro development following
vitrification of pronuclear and 8-cell stage mouse embryos. Mol. Reprod.
Dev. 73, 700–708.
Booth, P.J., Viuff, D., Tan, S., Holm, P., Greve, T., Callesen, H., 2003.
Numerical chromosome errors in day 7 somatic nuclear transfer bovine
blastocysts. Biol. Reprod. 68, 922–928.
Camargo, L.S.A., Powell, A.M., Filho, V.R.V.,Wall, R.J., 2005. Comparison of gene
expression in individual preimplantation bovine embryos produced by in vitro
fertilisation or somatic cell nuclear transfer. Reprod. Fertil. Dev. 17, 487–496.
Daniels, R., Hall, V., Trounson, A.O., 2000. Analysis of gene transcription in
bovine nuclear transfer embryos reconstructed with granulosa cell nuclei.
Biol. Reprod. 63, 1034–1040.
Daniels, R., Hall, V.J., French, A.J., Korfiatis, N.A., Trounson, A.O., 2001.
Comparison of gene transcription in cloned bovine embryos produced by
different nuclear transfer techniques. Mol. Reprod. Dev. 60, 281–288.
Dodge, J.E., Kang, Y.-K., Beppu, H., Lei, H., Li, E., 2004. Histone H3-K9
methyltransferase ESET is essential for early development. Mol. Cell. Biol.
24, 2478–2486.
Farin, C.E., Farin, P.W., Piedrahita, J.A., 2004. Development of fetuses from
in vitro-produced and cloned bovine embryos. J. Anim. Sci. 82, E53–E62
(E-Suppl).
Fischer-Brown, A., Crooks, A., Leonard, S., Monson, R., Northey, D., Rutledge,
J.J., 2005. Parturition following transfer of embryos produced in two media
under two oxygen concentrations. Anim. Reprod. Sci. 87, 215–228.
Hidalgo, C., Diez, C., Duque, P., Prendes, J.M., Rodriguez, A., Goyache, F.,
Fernandez, I., Facal, N., Ikeda, S., Alonso-Montes, C., Gomez, E., 2005.
Oocytes recovered from cows treated with retinol become unviable as
blastocysts produced in vitro. Reproduction 129, 411–421.
Hill, J.R., Burghardt, R.C., Jones, K., Long, C.R., Looney, C.R., Shin, T.,
Spencer, T.E., Thompson, J.A., Winger, Q.A., Westhusin, M.E., 2000a.
Evidence for placental abnormality as the major cause of mortality in first-
trimester somatic cell cloned bovine fetuses [In Process Citation] Biol.
Reprod. 63, 1787–1794.
Hill, J.R., Winger, Q.A., Long, C.R., Looney, C.R., Thompson, J.A., Westhusin,
M.E., 2000b. Development rates of male bovine nuclear transfer embryos
derived from adult and fetal cells. Biol. Reprod. 62, 1135–1140.
Hinchcliffe, E.H., 2003. Cell cycle: seeking permission from the mother
centriole. Curr. Biol. 13, R646–R648.
Hosack, D.A., Dennis Jr., G., Sherman, B.T., Lane, H.C., Lempicki, R.A., 2003.
Identifying biological themes within lists of genes with EASE. Genome
Biol. 4, R70.
Huang, F.J., Shen, C.C., Chang, S.Y., Wu, T.C., Hsuuw, Y.D., 2003. Retinoic
acid decreases the viability of mouse blastocysts in vitro. Hum. Reprod. 18,
130–136.
Huang, F.J., Hsu, Y.C., Kang, H.Y., Chang, S.Y., Hsuuw, Y.D., Huang, K.E.,
2005. Effects of retinoic acid on the inner cell mass in mouse blastocysts.
Fertil. Steril. 83, 238–242.
Humpherys, D., Eggan, K., Akutsu, H., Friedman, A., Hochedlinger, K.,
Yanagimachi, R., Lander, E.S., Golub, T.R., Jaenisch, R., 2002. Abnormal
gene expression in cloned mice derived from embryonic stem cell and
cumulus cell nuclei. Proc. Natl. Acad. Sci. U. S. A. 99, 12889–12894.
Jang, G., Jeon, H.Y., Ko, K.H., Bhuiyan, M.M.U., Park, H.J., Kang, S.K., Lee,
B.C., Hwang, W.S., 2004. Gene expression of preimplantation bovine
embryo derived somatic cell nuclear transfer using different donor cells.
Biol. Reprod. 225.
Jang, G., Jeon, H.Y., Ko, K.H., Park, H.J., Kang, S.K., Lee, B.C., Hwang, W.S.,
2005. Developmental competence and gene expression in preimplantation
bovine embryos derived from somatic cell nuclear transfer using different
donor cells. Zygote 13, 187–195.
649Z. Beyhan et al. / Developmental Biology 305 (2007) 637–649Kang, Y.K., Park, J.S., Koo, D.B., Choi, Y.H., Kim, S.U., Lee, K.K., Han, Y.M.,
2002. Limited demethylation leaves mosaic-type methylation states in
cloned bovine pre-implantation embryos. EMBO J. 21, 1092–1100.
Kato, Y., Tani, T., Tsunoda, Y., 2000. Cloning of calves from various somatic
cell types of male and female adult, newborn and fetal cows. J. Reprod.
Fertil. 120, 231–237.
Kikyo, N., Williamson, C.M., John, R.M., Barton, S.C., Beechey, C.V., Ball,
S.T., Cattanach, B.M., Surani, M.A., Peters, J., 1997. Genetic and
functional analysis of neuronatin in mice with maternal or paternal
duplication of distal Chr 2. Dev. Biol. 190, 66–77.
Kocabas, A.M., Crosby, J., Ross, P.J., Otu, H.H., Beyhan, Z., Can, H., Tam,W.L.,
Rosa, G.J., Halgren, R.G., Lim, B., Fernandez, E., Cibelli, J.B., 2006. The
transcriptome of human oocytes. Proc. Natl. Acad. Sci. U. S. A. 103,
14027–14032.
Latham, K.E., 2005. Early and delayed aspects of nuclear reprogramming during
cloning. Biol. Cell 97, 119–132.
Li, E., 2002. Chromatin modification and epigenetic reprogramming in
mammalian development. Nat. Rev., Genet. 3, 662–673.
Li, S., Li, Y., Du, W., Zhang, L., Yu, S., Dai, Y., Zhao, C., Li, N., 2005. Aberrant
gene expression in organs of bovine clones that die within two days after
birth. Biol. Reprod. 72, 258–265.
Li, X., Amarnath, D., Kato, Y., Tsunoda, Y., 2006. Analysis of development-
related gene expression in cloned bovine blastocysts with different
developmental potential. Cloning Stem Cells 8, 41–50.
Lima, P.F., Oliveira, M.A., Santos, M.H., Reichenbach, H.D., Weppert, M.,
Paula-Lopes, F.F., Neto, C.C., Goncalves, P.B., 2005. Effect of retinoids and
growth factor on in vitro bovine embryos produced under chemically
defined conditions. Anim. Reprod. Sci.
Mann, M.R.W., Chung, Y.G., Nolen, L.D., Verona, R.I., Latham, K.E.,
Bartolomei, M.S., 2003. Disruption of imprinted gene methylation and
expression in cloned preimplantation stage mouse embryos. Biol. Reprod.
69, 902–914.
Mirkin, S., Arslan, M., Churikov, D., Corica, A., Diaz, J.I., Williams, S., Bocca,
S., Oehninger, S., 2005. In search of candidate genes critically expressed in
the human endometrium during the window of implantation. Hum. Reprod.
20, 2104–2117.
Miyara, F., Han, Z., Gao, S., Vassena, R., Latham, K.E., 2006. Non-equivalence
of embryonic and somatic cell nuclei affecting spindle composition in
clones. Dev. Biol. 289, 206–217.
Natale, D., De Sousa, P., Westhusin, M., Watson, A., 2001. Sensitivity of bovine
blastocyst gene expression patterns to culture environments assessed by
differential display RT–PCR. Reproduction 122, 687–693. doi:10.1530/
rep.0.1220687.
Nolen, L.D., Gao, S., Han, Z., Mann, M.R., Gie Chung, Y., Otte, A.P.,
Bartolomei, M.S., Latham, K.E., 2005. X chromosome reactivation and
regulation in cloned embryos. Dev. Biol. 279, 525–540.
Ou, Y.Y., Mack, G.J., Zhang, M., Rattner, J.B., 2002. CEP110 and ninein are
located in a specific domain of the centrosome associated with centrosome
maturation. J. Cell Sci. 115, 1825–1835.
Pacheco, T.R., Gomes, A.Q., Barbosa-Morais, N.L., Benes, V., Ansorge, W.,
Wollerton, M., Smith, C.W., Valcarcel, J., Carmo-Fonseca, M., 2004.
Diversity of vertebrate splicing factor U2AF35: identification of alterna-
tively spliced U2AF1 mRNAS. J. Biol. Chem. 279, 27039–27049.
Pfaffl, M.W., Georgieva, T.M., Georgiev, I.P., Ontsouka, E., Hageleit, M., Blum,
J.W., 2002. Real-time RT–PCR quantification of insulin-like growth factor
(IGF)-1, IGF-1 receptor, IGF-2, IGF-2 receptor, insulin receptor, growth
hormone receptor, IGF-binding proteins 1, 2 and 3 in the bovine species.
Domest. Anim. Endocrinol. 22, 91–102.
Pfister-Genskow, M., Myers, C., Childs, L.A., Lacson, J.C., Patterson, T.,
Betthauser, J.M., Goueleke, P.J., Koppang, R.W., Lange, G., Fisher, P., Watt,S.R., Forsberg, E.J., Zheng, Y., Leno, G.H., Schultz, R.M., Liu, B., Chetia,
C., Yang, X., Hoeschele, I., Eilertsen, K.J., 2005. Identification of
differentially expressed genes in individual bovine preimplantation embryos
produced by nuclear transfer: improper reprogramming of genes required for
development. Biol. Reprod. 72, 546–555.
Rideout, W.M., Eggan, K., Jaenisch, R., 2001. Nuclear cloning and epigenetic
reprogramming of the genome. Science 293, 1093–1098.
Ruddock, N.T., Wilson, K.J., Cooney, M.A., Korfiatis, N.A., Tecirlioglu, R.T.,
French, A.J., 2004. Analysis of imprinted messenger RNA expression
during bovine preimplantation development. Biol. Reprod. 70, 1131–1135.
Sawai, K., Kageyama, S., Moriyasu, S., Hirayama, H., Minamihashi, A., Onoe,
S., 2005. Analysis of mRNA transcripts for insulin-like growth factor
receptors and binding proteins in bovine embryos derived from somatic cell
nuclear transfer. Cloning Stem Cells 7, 189–198.
Shi, W., Dirim, F., Wolf, E., Zakhartchenko, V., Haaf, T., 2004. Methylation
reprogramming and chromosomal aneuploidy in in vivo fertilized and
cloned rabbit preimplantation embryos. Biol. Reprod. 71, 340–347.
Smith, S.L., Everts, R.E., Tian, X.C., Du, F., Sung, L.Y., Rodriguez-Zas, S.L.,
Jeong, B.S., Renard, J.P., Lewin, H.A., Yang, X., 2005. Global gene
expression profiles reveal significant nuclear reprogramming by the
blastocyst stage after cloning. Proc. Natl. Acad. Sci. U. S. A. 102,
17582–17587.
Somers, J., Smith, C., Donnison, M., Wells, D.N., Henderson, H., McLeay, L.,
Pfeffer, P.L., 2006. Gene expression profiling of individual bovine nuclear
transfer blastocysts. Reproduction 131, 1073–1084. doi:10.1530/rep.1.00967.
Su, A.I., Cooke, M.P., Ching, K.A., Hakak, Y., Walker, J.R., Wiltshire, T., Orth,
A.P., Vega, R.G., Sapinoso, L.M., Moqrich, A., Patapoutian, A., Hampton,
G.M., Schultz, P.G., Hogenesch, J.B., 2002. Large-scale analysis of the
human and mouse transcriptomes. Proc. Natl. Acad. Sci. U. S. A. 99,
4465–4470.
Tsunoda, Y., Kato, Y., 2002. Donor cell type and cloning efficiency in mammals.
In: Cibelli, J., Lanza, R.P., Campbell, K.S., West, M.D. (Eds.), Principles of
Cloning. Academic Press, San Diego, pp. 267–275.
Tusher, V.G., Tibshirani, R., Chu, G., 2001. Significance analysis of microarrays
applied to the ionizing radiation response. Proc. Natl. Acad. Sci. U. S. A. 98,
5116–5121.
Van Thuan, N., Wakayama, S., Kishigami, S., Wakayama, T., 2006. Donor
centrosome regulation of initial spindle formation in mouse somatic cell
nuclear transfer: roles of gamma-tubulin and nuclear mitotic apparatus
protein 1. Biol. Reprod. 74, 777–787.
Wakayama, T., Rodriguez, I., Perry, A.C.F., Yanagimachi, R., Mombaerts, P.,
1999.Mice cloned from embryonic stem cells. Proc. Natl. Acad. Sci. U. S. A.
96, 14984–14989.
Wells, D.N., Misica, P.M., Tervit, H.R., 1999. Production of cloned calves
following nuclear transfer with cultured adult mural granulosa cells. Biol.
Reprod. 60, 996–1005.
Westhusin, M.E., Hill, J.R., Winger, Q.A., Jones, K.L., DeSousa, P.A., Watson,
A.J., 1999. Reprogramming gene expression following nuclear transfer into
bovine oocytes. Biol. Reprod. 60, 79.
Wrenzycki, C., Wells, D., Herrmann, D., Miller, A., Oliver, J., Tervit, R.,
Niemann, H., 2001. Nuclear transfer protocol affects messenger RNA
expression patterns in cloned bovine blastocysts. Biol. Reprod. 65,
309–317.
Wrenzycki, C., Herrmann, D., Lucas-Hahn, A., Lemme, E., Korsawe, K.,
Niemann, H., 2004. Gene expression patterns in in vitro-produced
and somatic nuclear transfer-derived preimplantation bovine embryos:
relationship to the large offspring syndrome? Anim. Reprod. Sci. 82–83,
593–603.
Zeng, F., Schultz, R.M., 2005. RNA transcript profiling during zygotic gene
activation in the preimplantation mouse embryo. Dev. Biol. 283, 40–57.
